Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer. Indian J Case Reports. 2024;10(10):322-324. doi:10.32677/ijcr.v10i10.4727